Matthew Abernethy

Matthew Abernethy

Director of Finance/CFO at NEUROCRINE BIOSCIENCES, INC.

Net worth: 7 M $ as of 2026-05-30

47 year
Health Technology
Consumer Services
Commercial Services

Profile

Matthew C. Abernethy is Chief Financial Officer at Neurocrine Biosciences, Inc. and Vice President-Finance of Biomet Orthopedics LLC. He is also on the board of BIOCOM. Mr. Abernethy previously held the position of Treasurer & Vice President-Investor Relations at Zimmer Biomet Holdings, Inc. Treasurer for Biomet, Inc. and Treasurer for Zimmer US, Inc. (both are subsidiaries of Zimmer Biomet Holdings, Inc.). Mr. Abernethy received an undergraduate degree from Grace College & Seminary and an MBA from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 42,808 ( 0.04% ) 7 M $ 2026-05-30
2026-03-30 0 ( -.--% ) - $ 2026-05-30

Matthew Abernethy active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Director of Finance/CFO 2017-10-31
DIUL GROUP Director/Board Member 2022-10-31
FATE THERAPEUTICS, INC. Director/Board Member 2025-05-28
SOLENO THERAPEUTICS, INC. Director/Board Member 2026-05-14
Director/Board Member -

Former positions of Matthew Abernethy

CompaniesPositionEnd
ZIMMER BIOMET HOLDINGS, INC. Public Communications Contact 2017-10-31
Investor Relations Contact 2017-10-31
Director of Finance/CFO 2015-05-31
Director/Board Member -
░░░░░░░ ░░░░ ░░░░░░░░░ -
See the detail of Matthew Abernethy's experience

Training of Matthew Abernethy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Matthew Abernethy
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!